Overview
Near-infrared Spectroscopy Neurofeedback as a Treatment for Children With Attention Deficit Hyperactivity Disorder
Status:
Unknown status
Unknown status
Trial end date:
2020-12-31
2020-12-31
Target enrollment:
0
0
Participant gender:
All
All
Summary
To observe the clinical efficacy and mechanism of functional near-infrared spectroscopy imaging neurofeedback therapy for attention deficit and hyperactivity disorder.Phase:
N/AAccepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Xijing HospitalTreatments:
Atomoxetine Hydrochloride
Methylphenidate
Criteria
For ADHD patients:Inclusion Criteria:
- diagnosed with TD, according to the American Diagnostic and Statistical Manual of
Mental Disorders, 5th Edition (DSM-5);
- aged 6-12;
- right handed;
Exclusion Criteria:
- full-scale intelligence quotient below 80(measured by Wechsler Intelligence Scale for
Children，WISC)
- medical or neurological disorders, psychiatric disorders other than oppositional
defiant disorder
- current participation in a psychotherapeutic treatment